Compounds > 4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine
Page last updated: 2024-09-03

4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine and nelfinavir

4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine has been researched along with nelfinavir in 1 studies

Compound Research Comparison

Studies
(4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine)		Trials
(4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine)		Recent Studies (post-2010)
(4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine)		Studies
(nelfinavir)		Trials
(nelfinavir)		Recent Studies (post-2010) (nelfinavir)
6001,240230240

Protein Interaction Comparison

ProteinTaxonomy4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine (IC50)nelfinavir (IC50)
Tyrosine-protein kinase FynHomo sapiens (human)7.971
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)8.852
ATP-dependent translocase ABCB1Homo sapiens (human)3.3938
Cytochrome P450 3A4Homo sapiens (human)1.275
ATP-dependent translocase ABCB1Mus musculus (house mouse)2.3
Sodium-dependent noradrenaline transporter Homo sapiens (human)8.852
Protease Human immunodeficiency virus 10.53
Protease Human immunodeficiency virus 10.0054

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1

Other Studies

1 other study(ies) available for 4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine and nelfinavir

ArticleYear
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009